Skip to main content
. 2024 Sep 26;5(1):720–726. doi: 10.1089/whr.2024.0039

Table 1.

Demographic, Obstetrical and Neonatal Information for Heparin versus Enoxaparin Groups. Statistical Significance is Based on the Logistic Regression. Continuous Variables Shown as Mean with Standard Deviation, Categorical Variables Shown as Number of Patients with Percentage of Group. NS = Not Significant; APGAR = Appearance, Pulse, Grimace, Activity, and Respiration scoring system

Variable Heparin N = 93 Enoxaparin N = 101 Statistical significance
Demographic information
 Age (SD) 30.9 (±6.2) 30.2 (±6.1) NS
 Body mass index (SD) 33.2 (±7.4) 35.0 (±9.4) NS
 Number of previous deliveries (SD) 1 (±2) 1 (±1) NS
Anticoagulation dosing
 Prophylactic dosing (%) 80 (86%) 59 (58%) NS
 Intermediate dosing (%) 4 (4%) 14 (14%) NS
 Therapeutic dosing (%) 9 (10%) 28 (28%) NS
Delivery timing
 Gestational Age at Delivery in weeks (SD) 38.3 (±2.5) 37.5 (±2.7) NS
 Spontaneous labor (%) 24 (26%) 22 (22%) NS
 Scheduled induction of labor (%) 52 (56%) 45 (45%) NS
 Scheduled cesarean delivery (%) 17 (18%) 34 (34%) NS
 Anticoagulation continued in labor (%) 10 (11%) 11 (11%) NS
Delivery details
 Concurrent sterilization (%) 8 (9%) 12 (12%) NS
 Vaginal delivery (%) 52 (56%) 50 (50%) NS
 Vacuum assisted delivery (%) 2 (2%) 10 (10%) NS
Obstetrical outcome
 Estimated blood loss in mL (SD) 497 (±378) 491 (±311) NS
 Ability to receive neuraxial anesthesia (%) 66 (71%) 72 (71%) NS
 Birthweight in kg (SD) 3.185 (±0.675) 2.970 (±0.766) NS
 1-minute APGAR (SD) 7 (±2) 7 (±2) NS
 5-minute APGAR (SD) 9 (±1) 9 (±1) NS
 Neonatology intensive care unit (NICU) admission (%) 22 (24%) 28 (28%) NS
 Postpartum blood transfusion (%) 6 (6%) 3 (3%) NS
 Readmission for hematoma or bleeding 0 0 n/a
 Reoperation 0 0 n/a
 Immediate postpartum thromboembolism 0 0 n/a